Intelligent Bio Solutions Inc
(INBS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2025 | 06-2024 | 06-2023 | 06-2022 | 06-2021 | |
| Sales | 3,053 | 3,112 | 1,995 | 0 | 1,981 |
| Cost of Goods | 1,806 | 1,686 | 930 | 0 | N/A |
| Gross Profit | 1,247 | 1,426 | 1,064 | 0 | 1,981 |
| Operating Expenses | 12,697 | 12,395 | 14,590 | 8,337 | 7,554 |
| Operating Income | -10,645 | -10,283 | -12,595 | -8,337 | -5,574 |
| Interest Expense | 61 | 167 | 224 | 8 | 1,094 |
| Other Income | 101 | 259 | 2,154 | 10 | -393 |
| Pre-tax Income | -10,605 | -10,191 | -10,665 | -8,334 | -7,060 |
| Net Income Continuous | -10,605 | -10,191 | -10,665 | -8,334 | -7,060 |
| Minority Interests | -36 | -34 | -33 | -28 | -23 |
| Net Income | $-10,569 | $-10,157 | $-10,632 | $-8,306 | $-7,037 |
| EPS Basic Total Ops | -20.00 | -63.80 | -1,270.00 | -1,360.14 | -1,632.65 |
| EPS Basic Continuous Ops | -20.11 | -63.97 | -1,273.88 | -1,364.91 | -1,627.60 |
| EPS Diluted Total Ops | -20.00 | -63.80 | -1,270.00 | -1,360.14 | -1,632.65 |
| EPS Diluted Continuous Ops | -20.11 | -63.97 | -1,273.88 | -1,364.91 | -1,627.60 |
| EPS Diluted Before Non-Recurring Items | -19.60 | -63.80 | -780.31 | -1,368.55 | -1,632.65 |
| EBITDA(a) | $-9,675 | $-9,309 | $-7,622 | $-8,337 | $-5,574 |